Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Ventilation (Perfluorocarbon) via NIPPV for Acute Lung Injury
ChiCTR-TRC-08000303Phase 4Completed
- Sponsor
- Medical Ethics Committee of Chinese PLA General Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of perfluorocarbon liquid in acute lung injury (ALI) (2 arms), sponsored by Medical Ethics Committee of Chinese PLA General Hospital. Primary endpoints: Length of ICU stay, Cost of ICU stay and 2 more. Started Aug 2007; status: completed.
02
Drugs
perfluorocarbon liquid
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on ChiCTR-TRC-08000303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000303.